In this article, the toxicology experts at Robson Forensic provide an introduction to some of the foundational principles relevant to their analyses, science, and casework. The principles and key…
In this article, Toxicologist and Drug Safety Expert, Michael Whitekus discusses the rising use of prescription drugs in the United States and introduces two models that can be used to evaluate causality as it relates to drug use.

When individuals develop debilitating health conditions, our experts in toxicology are often retained to determine if the negative health outcomes were caused by the use of specific prescription drugs or exposure to particular chemical agents.
There is a tendency among non-medical professionals to look at a temporal association as definitive proof of causation. However, the fact that a negative health outcome developed along with, or closely following, exposure to a particular substance does not prove causality.
Prescription drug use has increased significantly in the United States in recent years. Comparing the intervals 1988–1994 and 2007–2010, the percentage of Americans not taking any prescription drugs in the past 30 days decreased from 61% to 53% while those taking five or more drugs increased from 4% to 10% (see figure 1a). This is significant because adverse drug reactions exponentially increase when multiple drugs are used at the same time.
Prescription drug use is highest among older age groups. In 2007-2010, ~50% of adults aged 45 years and over reported taking one to four drugs in the past 30 days, compared with just ~23% of children. The percentage of people taking five or more drugs in the past 30 days increases with age, from less than 1% of children to ~40% of adults aged 65 and over (see figure 1b).
Drugs play an increasing role in the long-term treatment of chronic conditions. Some of the most commonly used prescription drug classes include cardiovascular, hyperlipidemia, anti-acid reflux, antidiabetes, analgesics and antidepressants. Among adults aged 65 and over, ~70% took at least one cardiovascular agent and ~47% took a cholesterol-lowering drug in the past 30 days in 2007–2010. Comparing the intervals 1988-1994 and 2007-2010 for adults aged 65 and over, all drug classes showed an increase in use (as did the 18-64 age group) with cardiovascular, 1.4-fold; cholesterol lowering, 7.9-fold; anti-acid, 2.9-fold; antidiabetes, 2-fold; anticoagulants, 3.0-fold; analgesics, 1.3-fold and antidepressants, 4.6-fold (see figure 2).
Not only has prescription drug use increased significantly but adverse drug events (any undesirable experience associated with the use of a drug) submitted to the FDA have also increased from ~13,000 in 2004 to ~52,000 in 2014. (see figure 3).
Increased single and multiple drug use would be expected to increase the number of adverse drug events. On the next page we introduce two tools to help you evaluate the causality of any potential adverse drug case.

A set of criteria to determine if an association is causal was published in 1965 by epidemiologist Bradford Hill. Hill proposed nine criteria which outlined how to critically evaluate the causal link between a specific factor and some undesirable outcome. The principles contained in Hill’s nine criteria (originally applied to cancer causation) are applicable in evaluating causality in a number of different areas, including adverse drug reactions.
The Adverse Drug Reaction (ADR) Probability Scale or Naranjo scale is a set of 10 questions designed to help standardize assessment of causality for all adverse drug reactions. Once the questions are answered a score is generated which can be used to help assess the certainty that a particular outcome was caused by a particular agent.

For more information, submit an inquiry or contact one of our featured experts.
In this article, the toxicology experts at Robson Forensic provide an introduction to some of the foundational principles relevant to their analyses, science, and casework. The principles and key…